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Multivariate classification 
techniques and mass spectrometry 
as a tool in the screening 
of patients with fibromyalgia
Marcelo V. S. Alves1, Lanaia I. L. Maciel2, Ruver R. F. Ramalho2, Leomir A. S. Lima3, 
Boniek G. Vaz2, Camilo L. M. Morais4, João O. S. Passos5, Rodrigo Pegado5 & 
Kássio M. G. Lima1*
Fibromyalgia is a rheumatological disorder that causes chronic pain and other symptomatic conditions 
such as depression and anxiety. Despite its relevance, the disease still presents a complex diagnosis 
where the doctor needs to have a correct clinical interpretation of the symptoms. In this context, 
it is valid to study tools that assist in the screening of this disease, using chemical work techniques 
such as mass spectroscopy. In this study, an analytical method is proposed to detect individuals with 
fibromyalgia (n = 20, 10 control samples and 10 samples with fibromyalgia) from blood plasma samples 
analyzed by mass spectrometry with paper spray ionization and subsequent multivariate classification 
of the spectral data (unsupervised and supervised), in addition to the treatment of selected variables 
with possible associations with metabolomics. Exploratory analysis with principal component analysis 
(PCA) and supervised analysis with successive projections algorithm with linear discriminant analysis 
(SPA-LDA) showed satisfactory results with 100% accuracy for sample prediction in both groups. This 
demonstrates that this combination of techniques can be used as a simple, reliable and fast tool in the 
development of clinical diagnosis of Fibromyalgia.
Fibromyalgia (FM) is a rheumatologic disorder that causes chronic pain and other symptomatic conditions such 
as depression, anxiety and sleep and memory  disorders1,2. This disorder is common in clinical rheumatology 
routine, with a worldwide prevalence between 0.5 and 5%, affecting women approximately seven times more than 
 men3. Despite its relevance, the disease still has a complex diagnosis where the physician needs to have a correct 
clinical interpretation of the symptoms, since they are similar to other rheumatologic  diseases3,4.
The correct diagnosis of this disorder requires studies on tools that help in the screening of individuals affected 
with this disease. One of the techniques used for this purpose is Mass Spectrometry (MS) coupled with Liquid 
Chromatography techniques (LC–MS)5 e Gas Chromatography (GC–MS)6. These techniques have a high analyti-
cal performance, but they require laborious and extensive sample preparation procedures, high consumption of 
solvents and reagents, and generate chemical  residues7. Thus, it is necessary to develop analytical methods that 
prioritize the resolution of these problems. With Ambient Mass Spectrometry (AMS)8, and the introduction of 
techniques such as: direct Analysis in Real Time (DART) and Desorption Electrospray Ionization (DESI), there 
is a new way to generate ions in  MS7,9. AMS is characterized by ion generation under ambient conditions and 
direct compound analysis in its native environment with minimal or no sample  preparation10.
Among the various techniques belonging to this group, there is the speed and versatility of Paper Spray Ioniza-
tion (PSI)11. In PSI, the sample  (liquid12 or  solid13) is deposited on the surface of a triangular paper followed by 
the application of a high voltage and solvent, forming a spray on the tip of this paper containing sample droplets 
that are sent to the  MS14. This method facilitates the analysis of biofluids quickly and  quantitatively15. PSI is 
applicable to a wide range of biological compounds, including peptides, small nucleotides, phospholipids and 
other organic  compounds16, being used in the quantification of drugs in the plasma of  patients17 and in clinical 
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studies predicting some types of  cancer18,19. Considering that there is no standard instrumental technique for 
fibromyalgia, the diagnosis is clinical by elimination. The PSI-MS technique was chosen because it is innova-
tive, does not require sample preparation and has a very relevant analytical power, lowering analysis costs when 
compared to ESI–MS, for example, and can be implemented in hospital routines.
In view of the versatility of the PSI method and in order to better understand the resulting results, it is worth 
involving an analysis of the metabolites so that it is possible to identify and quantify the main metabolites of the 
biological  system20. Metabolomic analysis is typically characterized in two  approaches21: targeted approach on 
selected metabolite or metabolite class with known chemical properties; and untargeted approach, measuring all 
possible metabolites providing hypotheses for further testing. The study of metabolomics contributes to a bet-
ter understanding of the biological characteristics of different types of  cancer22, as well as in understanding the 
association with indicator biomolecules for the diagnosis of  fibromyalgia23. To make this possible, multivariate 
statistical analysis is commonly  used24, where the combinatorial effect of multiple variables is considered and 
can be characterized in unsupervised techniques, which refer to methods that identify hidden structures in the 
data without knowing the class labels, and supervised techniques that use the information from the class label 
to build the classification  model21.
Several types of chemometric algorithms are reported for pattern recognition and classification of MS data, in 
particular to discriminate between healthy and cancer  samples24. Some reports on the investigation of biological 
and metabolomic markers in biofluids from patients with FM are also located in the  literature23,25,26, but without 
the occurrence of application of chemometric tools for group classification. In a recent  study2 the blood plasma of 
control and fibromyalgia patients is used, in which it was possible to reach good results of discrimination of these 
groups from infrared (IR) spectroscopic analysis coupled with chemometric techniques. In this case, despite the 
good results in IR, the spectra obtained are difficult to interpret and have low resolution for elucidating molecules 
of clinical interest, and consequent detection of FM in blood smear. However, working with IR provides a good 
suggestion for using classification tools, seeking to optimize the best performance results.
In this study, nine algorithm combinations were used (PCA-LDA, PCA-QDA, PCA-SVM, SPA-LDA, SPA-
QDA, SPA-SVM, GA-LDA, GA-QDA and GA-SVM) that are executed and compared to discriminate between 
blood plasma samples from control and fibromyalgia patients. These algorithms used the spectra obtained 
through the PSI-MS technique, providing a practical and reliable method without complex sample preparation. 
In addition, associations of selected variables with already cataloged metabolites are also explored, indicating 
the possible presence of biological fingerprints in the study groups.
Results
It is possible to visualize in Fig. 1 the overlap along the MS signal that does not allows visual differentiation 
between the control group (CG) and the fibromyalgia group (FG). The raw spectra are pre-processed with 
weighted automatic least squares baseline correction and vector  normalization27. Spectral samples were divided 
into training (70%) and test (30%) groups using the Kennard-Stone sample selection algorithm. In this division, 
the set of training samples is used in the construction of the model, while the set of test samples are used in the 
prediction of model performance. The spectra resulting from the pre-processing are submitted to classification 
of FG and CG groups. Classification was performed with algorithm combinations like Principal Component 
Analysis (PCA), Successive Projection Algorithm (SPA) and Genetic Algorithm (GA) combined with supervised 
algorithm like Linear Discriminant Analysis (LDA), Quadratic Discriminant Analysis (QDA); and, Support Vec-
tor Machines (SVM); proposing PCA-LDA, PCA-QDA, PCA-SVM, SPA-LDA, SPA-QDA, SPA-SVM, GA-LDA, 
GA-QDA and GA-SVM models to optimize the results and identify those with the best performances.
To start distinguishing between classes, pattern recognition algorithms were used. At first, the PCA is used 
as an exploratory analysis for the dataset, where the score plots with confidence ellipse are shown in Fig. 2. The 
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plot of scores of the first two principal components (PC1 and PC2) demonstrate a good separation of the two 
classes, with the samples from the control group clustered in a region different to the samples from the case group. 
The presence of a sample from the control group displaced to the right of the others is also visible, which may 
indicate an outlier and the presence of a patient with FM in the control group. For this initial analysis, sensitivity 
and specificity calculations were made with 100% accuracy in discriminating groups. These results suggest the 
PCA as a good tool for classification, demonstrated in the pattern of discrimination observed in the score plots.
Despite the good performance of the exploratory analysis, it is possible to observe that the confidence ellip-
ses demonstrate a large region of intersection between groups, which proposes a more elaborate exploratory 
method. We opted for subsequent supervised analyzes, also considering the limited number of samples and 
confirmation of the results. In the further investigation of the data, supervised discriminant analyzes (LDA and 
QDA) associated with PCA data reduction were used. In this case, the first 5 principal components (PC) were 
applied with an accumulated explained variance of 76.33%. For these models, the results are more expressive 
for linear classification techniques, with 100% sensitivity and specificity for the control group, while for the 
group of people with FM the values decrease to 33.3% (Table 1). By associating variable selection techniques 
with discriminant analyzes in SPA-LDA, SPA-QDA, GA-LDA and GA-QDA, the best results are observed for 
the supervised methods obtained in this study, in which the SPA-LDA model presented 100% accuracy in both 
classes and the GA-LDA model with 95.8% accuracy for the CG and 73.6% for the FG. The low results in the other 
models, especially in the QDA combinations, may imply a bad adjustment due to the absence of large differences 
in the variance structures between the  classes28. For the mentioned LDA models, as well as the good classification 
results, the possibility of exploring the most significant variables in the distinction of the GC and GF groups can 
also be demonstrated, which comprise the investigation of possible relationships with the metabolomics present 
in the biological samples of individuals participants from each class (Table 2).
Figure 2.  PCA scores on PC1 versus PC2 for samples from the control group and the FM group, with 
confidence ellipse in each group. The percentage of total variance is described for each PC (in parentheses). The 
blue dotted circle represents a 95% confidence level.
Table 1.  Sensitivity and specificity results, in percentage, for the control group and with FM, demonstrating 
the effectiveness in classifying the groups using the supervised models.
Model
Control group Fibromyalgia group
Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%)
PCA-LDA 100 100 33.3 33.3
SPA-LDA 100 100 100 100
GA-LDA 100 91.7 69.4 77.8
PCA-QDA 50 0 0 0
SPA-QDA 100 100 33.3 33.3
GA-QDA 35 0 43.3 0
PCA-SVM 100 100 66.7 66.7
SPA-SVM 66.7 66.7 100 100
GA-SVM 38.9 38.9 100 87.5
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Another supervised technique of nonlinear classification, in addition to QDA, used in this paper in search 
of best results, was the SVM using the Polynomial Base Function (PBF) kernel for the spectral dataset, as indi-
cated in a study with blood  samples29. For the PCA-SVM, good performance was presented for the CG group 
with 100% accuracy (Table 1). With the SPA-SVM and GA-SVM variable selection algorithms, the results also 
indicate good distinctions between CG and FG, with emphasis on the classification of the group with FM in 
the SPA-SVM model with 100% accuracy in this group, and the GA-SVM where 100% sensitivity and 91.66% 
specificity were achieved for individuals with the disease. Associations with metabolomics were also raised for 
the small set of selected variables (Table 2).
In the supervised models with variable selection, for a universe with more than 900 variables present in the 
MS dataset, a total of sixty-six values were collected due to the need for three executions of the GA models, 
because it is a non-deterministic algorithm. Thus, among the variables represented in more than one model there 
are: 65, 77, 118, 173, 360, 390 and 475 m/z. Among these m/z values, the 118 m/z is present in three different SPA 
models. These selected variables and for those indicated in the differences between the class means and chemical 
profile of the samples in the PCA (Fig. 3) forward to the study of metabolites.
Platforms with information in the human metabolomics database such as  HMDB30, LIPID  MAPS31 and 
 PubChem32 were used. Among the compounds identified from the m/z values selected in all worked models, 
the following classes of compounds are observed: organics acids and derivatives, inorganic compound, nucleo-
tides, benzenoids, organohalogen and organosulfur. For the value 118 m/z the database directed to compounds 
organoheterocyclics.
The observations were carried out on the HMDB and LIPID MAPS platforms following the positive mode ion 
settings in M + H and molecular mass tolerance in ± 0.01 m/z. Among the identified metabolites, those with the 
highest value attributed are Lysophosphatidylcholine (LysoPC) found in the HMDB library as LysoPC (16:1/0:0) 
Table 2.  Selected variables (m/z) in PCA and supervised models.
MODEL Table with selected variables (m/z)
PCA (PC1) 173 217 261 339 370 519 781
PCA (PC2) 173 217 261 370
SPA-LDA 1 118
GA-LDA
55 360 376 475 592
10 44 475 544 602 638 658
64 525 649 651 791 832
SPA-QDA 77 118
GA-QDA
65 135 202 307 450 528 745 823 887 898
108 330 365 493 520 605 693 751 777 847
19 76 163 231 322 360 374 487 589 833
SPA-SVM 77 118
GA-SVM
65 77 80 95 167 194 390 590 593 698
3 112 138 173 280 348 482 610 833 878
77 218 296 390 457 646
Figure 3.  The spectral mean with all samples, the difference between the spectral means (DBM) and the 
chemical profile of the samples for PC1 are shown.
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and LysoPC (18:2/0:0) compounds. In the LIPID MAPS platform there was no association with any information 
from the database about these compounds. The relationship with the compound LysoPC (16:4) was indentified 
on the PubChem platform and the other metabolites of the HMDB library were confirmed.
Discussion
Studies carried out by the American College of Rheumatology offer good results for differentiating between 
groups of patients with and without fibromyalgia, taking into account the occurrence of 11 of the 18 sensi-
tive pain points for FM  symptoms33, the accuracy obtained in this classification was 84.9% with a sensitivity 
of 88.4%. In a more recent study using blood plasma samples from groups with and without FM and readings 
in mid-infrared spectroscopy coupled with multivariate  classification2, the accuracy results reached values of 
84.2% and sensitivity of 89.5% using the GA-LDA model. For this paper, using paper spray ionization mass 
spectrometry, the best results provided 100% accuracy for SPA-LDA, in addition to classification with PCA that 
also recognized all case group (FG) samples as patients with fibromyalgia. When comparing these results it is 
possible to observe good values for distinction between the classes, but the emphasis is on the SPA-LDA model 
through the PSI-MS analysis technique, which indicates the good potential of this methodology as a support in 
the screening for the disease.
Thus, the use of different classification methods aims to expand the possibilities of satisfactory results. In the 
case of unsupervised analysis with PCA, in addition to demonstrating good ability to separate the groups, the use 
also aimed to reduce multivariate data in order to match the complexity of the subsequent supervised classifiers, 
with quantities of data available to avoid overfitting or under-training34. The good results with PCA can be related 
to the reduced number of samples, which could also to indicate the impossibility of using supervised techniques. 
However, this study explores the potential of MS for the smallest number of samples, considering that MS has 
high analytical sensitivity for small amounts of available biological fluids, demonstrating high resolution with 
accurate mass data for structural  elucidation35. The SPA and GA algorithms, through the calculations performed 
to classify the groups, also indicate selected variables that may be associated with the presence of FM in the case 
group. The LDA supervised models are recurrent in several clinical studies of this nature, such as in  cancer36,37 
and viral  diseases38–40, because they work with processes with less complex characteristics. It is also common in 
the literature to find similar studies that expand the classifications to more robust models such as  QDA41,42 and 
 SVM43, other researches seek to further expand the treatment of spectral samples, submitting them to these three 
types of techniques (LDA, QDA and SVM) and comparing the better accuracy results given the complexities of 
multivariate  data2,24. This last approach is worked on and observed in this article.
This work also explored the possibility of associating variables selected by the models used with metabolomics 
cataloged in the literature in order to indicate possible biochemical markers in the identification of patients with 
FM. Among sixty-six selected variables, from a universe with more than 900 variables representing the range 
of mass/charge ratios analyzed, eight m/z ratio values are recurrent in more than one model while the 118 m/z 
variable is suggested by all SPA models. Despite not identifying new metabolites present in the database, the 
observation of greatest interest is to confirm the presence of Lysophosphatidylcholine (LysoPC)  compounds30 
suggested by a study of patients with FM indicating a possible role of LysoPC as a biomarker, with results indi-
cating an increase in this metabolite in patients with  Fibromyalgia44.
The exploratory analysis with PCA and the supervised analysis with SPA-LDA demonstrated satisfactory 
results with 100% accuracy for predicting samples in both groups (CG and FG) using the PSI-MS technique. 
Other models had more reasonable values such as GA-LDA, PCA-SVM and SPA-SVM, which may indicate 
overtraining for the SPA-LDA model, but all classification techniques were submitted to confounding tests that 
validate the effectiveness of the tool, which it consists of new processing with the mutual exchange between the 
CG and FG groups to try to deceive the mathematical model. The representation of variables selected by the 
models also indicated possible lines of investigation for the understanding of biological fingerprints in the iden-
tification of patients with FM, despite the absence of new metabolites associated with these variables in the refer-
enced database, based on blood samples, it was possible to confirm the presence of Lysophosphatidylcholine that 
represent compounds associated with the disease, according to the literature. Regarding the results found in the 
classification analyses, the study proposes the best results for two simple and easy to perform algorithms, when 
compared to the others. The results of this study also surpass the reference methods already used, demonstrating 
another method with good efficacy in FM screening. Despite the optimistic results, it is worth remembering that 
the sample universe was reduced when compared to the reference methods. Another important consideration 
is the size of the blood sample collected, as only plasma is used in the instrumental analysis, keeping the main 
biochemical information, which may indicate that statistics are kept for larger samples.
Thus, considering that the experimental technique with PSI-MS and spectral analysis by using PCA as an 
unsupervised technique and SPA-LDA as a supervised technique reach 100% sensitivity and specificity for both 
classes of individuals with FM and without the disease, this has promising potential as an analytical approach 
with good clinical outcomes. This combination of techniques can be used as a simple, reliable and fast tool in 
making clinical diagnosis of Fibromyalgia. In addition to these considerations, the detection of metabolomics is 
also a positive factor in the study, proposing the association of this information with possible biological markers 
for the disease.
Methods
Sample. This case–control study was performed following the ethics standards of the Declaration of Helsinki 
and was approved by the local institutional ethics committee at the Onofre Lopes University Hospital (Federal 
University of Rio Grande do Norte, Natal, Brazil) under registration number 2.631.168. Informed consents were 
obtained from all subjects of this study; and all experimental protocols complied with the ethics guidelines. For 
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this study, 20 plasma samples were selected, 10 samples from patients in the control group and 10 samples from 
patients with FM. Data were collected from July 2018 to March 2019 and recruitment was carried out through-
out this period. The study was carried out at the Clinical Epidemiological Laboratory of the Federal University 
of Rio Grande do Norte, Natal (RN), Brazil. Sociodemographic data (gender, age, education, occupation, marital 
status and ethnicity), clinical data (impact of fibromyalgia, anxiety, pain and quality of life) and 10 mL of blood 
were collected from each patient on the same day. In the Supplementary Information, further conditions for 
sample collections are described (S1).
Conventional PSI-MS. For each selected plasma sample, a small 0.05 mL aliquot was removed and applied 
to triangular paper (Whatman grade 1, GE healthcare, USA, with 1.5 cm sides) left at room temperature (25 °C) 
until drying. Triangular papers containing small aliquots of blood were positioned in front of the mass spec-
trometer (at a distance of 4 mm between the tip of the paper and the entrance of the mass spectrometer). The 
dry paper was held by a metal clip connected to the voltage source of the mass spectrometer, with the tip of the 
paper at a distance of approximately 5 mm. 10 µL of methanol (0.1% formic acid v/v) was applied to the paper to 
form the electrospray for MS analysis. Analyzes were performed in triplicate measures.
Instrumental parameters. Mass spectra were obtained using a Thermo Scientific LTQ-XL Linear Ion 
Trap spectrometer. The optimized parameters were as follows: negative ionization mode; capillary temperature 
275 °C; 15 V capillary voltage; 4 kV spray voltage; tube lens 50 V. Mass spectra were acquired using Thermo Tune 
plus software and processed for chemometric analyzes using Xcalibur Analysis package software (version 2.0, 
Service release 2, Thermo Electron Corporation).
Computational analysis. Spectral data were processed using MATLAB R2014b software (MathWorks 
Inc., Natick, USA) with PLS Toolbox version 7.8 (Eigenvector Research Inc., Wenatchee, USA). The set of spec-
tral samples was subjected to pre-processing with weighted automatic least squares baseline correction and vec-
tor normalization. Spectral samples were divided into training (70%) and test (30%) groups using the Kennard-
Stone sample selection algorithm. In this division, the set of training samples is used in building the model, while 
the set of testing samples are used in predicting the model’s performance. The description of the classification 
methods used in this study can be found in the Supplementary Information (S2).
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